Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer
Fibromyalgia
United States Naval Medical Center, Portsmouthmonoclonal_antibodyPhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
11 Active assets in the Fibromyalgia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Duloxetine Cukurova University | Phase 4 | BBB |
Pregabalin Yung Shin Pharm. Ind. Co., Ltd. | Phase 4 | BB |
Piperazine, 1-(Bis(4-Fluorophenyl)Methyl)-4-(3-Phenyl-2-Propenyl)-, (E)- Taipei Veterans General Hospital, Taiwan | Phase 4 | BB |
Lidocaine Peking University Third Hospital | Phase 2 | BB |
Gabapentin Good Samaritan Regional Medical Center, Oregon | Phase 3 | B |
View all 33 →
Same molecule, other indications
Immunoglobulin G, Anti-(Human Calcitonin Gene-Related Peptide Receptor) (Human Monoclonal Heavy Chain), Disulfide With Human Monoclonal Light Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →